RNatives

Finland
Kuopio, North Savo, Finland, 70150

Company profile

RNatives company profile

RNatives specializes in the field of biotechnology, focusing on the development of innovative RNA-based therapies. The company's expertise lies in RNA activation, particularly targeting VEGFA for the treatment of cardiovascular diseases. RNatives is dedicated to advancing its lead programs through rigorous research and development, aiming to offer novel therapeutic options for conditions with unmet medical needs. With a team of skilled professionals, RNatives is committed to pushing the boundaries of biotechnology to improve patient outcomes.

Business identity

Contact email
[email protected]
Phone number
358 50 553 8558
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2020-01-01, Year

Headquarters

Postal code
70150
Country code
FI
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
2
Total equity funding
$1.6M
Last funding
Seed / $1.6M / 2025-05-27
Last equity funding
Seed / $1.6M
Investors
3
Lead investors
1
Articles
2

Founders and investors

Lead investors

Nordic Science Investments

Investors

Business FinlandForce 10 PartnersNordic Science Investments